Table II.
Expression of RECK and MMP-2 in SACC, benign salivary tumors and normal cases.
| Group | Total (n) | RECK | χ2 | P-value | MMP-2 | χ2 | P-value | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
||||||||||||
| − (n) | + (n) | ++ (n) | PP (%) | − (n) | + (n) | ++ (n) | PP (%) | ||||||
| SACC | 83 | 62 | 9 | 12 | 25.3 | 25.007 | 0.000 | 14 | 29 | 40 | 83.1 | 25.405 | <0.0001 |
| BST | 27 | 14 | 7 | 6 | 48.1 | 7 | 9 | 11 | 74.1 | ||||
| NC | 16 | 2 | 5 | 9 | 87.5 | 12 | 4 | 0 | 25.0 | ||||
ACC, adenoid cystic carcinoma; BST, benign salivary tumors; NC, normal cases; PP, percentage of positive; RECK, reversion-inducing cysteine-rich protein with Kazal motifs; MMP-2, matrix metalloproteinase-2.